Research study Program year 2020 Source: CMS Open Payments

Zoster-049

Research payments

$953,203

836 payments

Through program year 2020, $953,203 in research payments was reported against Zoster-049, across 836 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$441,504	366
2019	Research	$511,698	470

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $953,203 836 payments

Who received the money Research payments · program years 2019–2020

Pmg Research Organisation paid for research $341,210 302 payments
Clinical Research Advantage INC-Tempe-U Organisation paid for research $98,168 111 payments
Rapid Medical Research Organisation paid for research $94,640 67 payments
Centennial Medical Group PA Organisation paid for research $90,297 43 payments
Preferred Primary Care Physicians INC Organisation paid for research $88,167 47 payments
Lung Diagnostics Ltd Organisation paid for research $61,874 71 payments
Pmg Research INC Organisation paid for research $55,553 50 payments
Encompass Clinical Research Organisation paid for research $23,085 23 payments
Radiant Research Organisation paid for research $19,980 23 payments
Heartland Research Associates Organisation paid for research $15,120 24 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.